The anxiety-reducing drug, Clonazepam, has been recalled after a potentially "life-threatening" label mix-up, the Food and Drug Administration (FDA) said. According to a release from the federal ...

Jurors apparently got an eyeful last Friday in the Sean “Diddy” Combs sex trafficking trial in New York City. That’s when ...

Endo, Inc. issued a voluntary recall for Clonazepam tablets “due to potential product carton strength mislabeling.” In the ...

Tablets of the drug clonazepam, the generic name for Klonopin, which is used to treat epilepsy, panic disorder and muscle spasms, have been recalled for incorrect labeling that could inadvertently ...

Incorrect strength labels sparked the recall, according to the manufacturer. Clonazepam pill bottle pictured in this stock image. STOCK PHOTO/Getty Images Additional packages of clonazepam ...

The anti-anxiety medication clonazepam is produced on multiple continents, making it vulnerable to shocks such as tariffs, ...

The Pennsylvania-based drug maker Endo announced this week that it is expanding its recall of clonazepam tablets because some cartons bear the incorrect drug strength and wrong drug code.

Some packages of clonazepam were labeled with the incorrect dosage strength and National Drug Code (NDC), which is the FDA's identifier for drugs, according to Endo, Inc., the drug's manufacturer.